ProQR Therapeutics NV (NASDAQ:PRQR)
| 0.7995 BATS BZX Real-Time Price As of 3:08pm ET |  +0.0496 / +6.61%Today’s Change | 0.53 Today|||52-Week Range 8.67 | -90.02% Year-to-Date |
Institutional investors purchased a net $9.9 million shares of PRQR during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 31.99% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 17.99% |
| Mutual fund holders | 14.00% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/07/2022 | MIRAE ASSET GLOBAL INVESTMENTS C... Sold 103.00 shares of ProQR Therapeutics NV |
Top 10 Owners of ProQR Therapeutics NV
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Privium Fund Management BV | 7.50% | 5,344,446 | 4,222,112 | +100,000 | +1.91% |
| Adage Capital Management LP | 4.63% | 3,300,000 | 2,607,000 | 0 | 0.00% |
| Opaleye Management, Inc. | 3.84% | 2,740,000 | 2,164,600 | +315,000 | +12.99% |
| Prosight Management LP | 2.40% | 1,707,509 | 1,348,932 | +1,108,221 | +184.92% |
| FIL Investment Advisors (UK) Ltd. | 1.48% | 1,058,091 | 835,892 | -47,002 | -4.25% |
| JPMorgan Asset Management (UK) Lt... | 1.35% | 961,511 | 759,594 | 0 | 0.00% |
| Monaco Asset Management SAM | 1.31% | 931,400 | 735,806 | +840,500 | +924.64% |
| Renaissance Technologies LLC | 1.30% | 929,000 | 733,910 | +324,819 | +53.76% |
| Macquarie Investment Management B... | 0.87% | 620,000 | 489,800 | 0 | 0.00% |
| De Grote Voskuil Capital BV | 0.77% | 550,000 | 434,500 | +100,000 | +22.22% |
Top 10 Mutual Funds Holding ProQR Therapeutics NV
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Aescap Life Sciences | 6.69% | 4,765,659 | 3,764,871 | +1,618,176 | +51.41% |
| JPMorgan Funds - Thematics - Gene... | 1.35% | 961,511 | 759,594 | +255,975 | +36.28% |
| Fidelity Funds SICAV - European S... | 1.26% | 899,255 | 710,411 | 0 | 0.00% |
| Delaware Healthcare Fund | 0.87% | 620,000 | 489,800 | 0 | 0.00% |
| Hoofbosch Beleggingsfonds | 0.77% | 550,000 | 434,500 | +100,000 | +22.22% |
| iShares Biotechnology ETF | 0.64% | 454,067 | 358,713 | -2,527 | -0.55% |
| FCP Medical - BioHealth | 0.60% | 429,788 | 339,533 | 0 | 0.00% |
| Xtrackers SICAV - MSCI World Swa... | 0.46% | 328,364 | 259,408 | 0 | 0.00% |
| CI Global Health Sciences Corpora... | 0.45% | 321,360 | 253,874 | 0 | 0.00% |
| APO Medical Opportunities | 0.15% | 105,009 | 82,957 | +105,009 | -- |